MedTrace Logo

Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Parkinson Disease

NCT02969941 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2019-03-20

No results posted yet for this study

Summary

To investigate the treatment effect of continuous transcranial magnetic stimulation on patients with Parkinson disease, and the underlying neural mechanism by functional MRI

Conditions

  • Transcranial Magnetic Stimulation
  • Functional Magnetic Resonance Imaging
  • Parkinson Disease

Interventions

OTHER

transcranial magnetic stimulation

The stimulations were performed by MagStim Rapid2.

Sponsors & Collaborators

  • Anhui Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2019-01-01
Completion
2019-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02969941 on ClinicalTrials.gov